한국어 · English · 简体中文 · Русский · Bahasa Indonesia · ภาษาไทย · Tiếng Việt · 日本語

Approved ingredients

루테인지아잔틴추출복합물

루테인지아잔틴추출복합물

MFDS recognition no.2023-37
Approval routeNotified (고시형) — listed in MFDS public standards
Daily intake (as approved)12.0–12.0 mg/일
Approval holder한국암웨이(주)

Approved wording (Korean original)

노화로 인해 감소될 수 있는 황반색소밀도를 유지하여 눈 건강에 도움을줄 수 있음

Precautions (Korean original)

영‧유아, 어린이, 임산부 및 수유부는 섭취에 주의/과다 섭취 시 일시적으로 피부가 황색으로 변할 수 있음/이상사례 발생 시 섭취를 중단하고 전문가와 상담할 것/흡연자는 섭취 시 전문가와 상담할 것
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.